OLETF (Otsuka Long-Evans Tokushima Fatty) rats that lack the CCK 1 (A) receptor develop less behavioral sensitization to repeated cocaine treatment than wild type LETO (Long Evans Tokushima Otsuka) rats

Peptides

Volumn 22, Issue 8, 2001, Pages 1285-1290

  Beinfeld, Margery C ^a   Connolly, Kelly ^a   Pierce, R Christopher ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CCK; CCK 1 receptor; Cocaine sensitization; OLETF rat

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ 1 (A) RECEPTOR; CHOLECYSTOKININ RECEPTOR; COCAINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; HORMONE RELEASE; HYPOTHESIS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SENSITIZATION; STEREOTYPY; STRAIN DIFFERENCE;

ANIMALS; BEHAVIOR; COCAINE; DOPAMINE UPTAKE INHIBITORS; MALE; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; TIME FACTORS;

EID: 0034906067     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00453-3     Document Type: Article

References (36)

1. Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis
2. The distribution of cholecystokinin in the central nervous system of the rat as determined by radioimmunoassay
3. Cholecystokinin release from the rat caudate-putamen, cortex, and hippocampus is increased by activation of the D1 dopamine receptor
4. Cholecystokinin-dopamine interactions
5. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway
6. The expression of behavioral sensitization to amphetamine: Role of CCK(A) receptors
7. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor
8. A receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: Comparison with the dopamine antagonist haloperidol
9. Evidence for coexistence of dopamine, and CCK in mesolimbic neurons
10. Behavioral, and neurochemical sensitization following cocaine self-administration
11. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission
12. A receptor involvement in the acquisition of conditioned activity produced by cocaine in rats
13. A receptor antagonist
14. Time course of extracellular dopamine, and behavioral sensitization to cocaine. I. Dopamine axon terminals
15. Dopamine transmission in the initiation, and expression of drug-, and stress-induced sensitization of motor activity
16. DNQX blockade of amphetamine behavioral sensitization
17. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats
18. Time course of the development of the enhanced behavioral, and biochemical responses to amphetamine after pretreatment with amphetamine
19. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens, and facilitates motivation, and attention after intraperitoneal (i.p.) injection in rats
20. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens
21. 2 receptors in rat forebrain sections
22. Protein measurement with the folin phenol reagent
23. Origin of cholecystokinin containin fibers in the rat caudatoputamen
24. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene
25. Disordered food intake, and obesity in rats lacking cholecystokinin A receptors
26. Cholecystokinin in cortico-striatal neurons in the rat: Immunohistochemical studies at the light, and electron microscopical level
27. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization
28. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine
29. Enduring changes in brain, and behavior produced by chronic amphetamine administration: A review, and evaluation of animal models of amphetamine psychosis
30. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats
31. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward, and related behaviors
32. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
33. Cholecystokinin modulates both the development, and expression of behavioral sensitization to amphetamine in the rat
34. Blockade of behavioral sensitization to methamphetamine by lesion of hippocampo-accumbal pathway
35. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: An in vivo microdialysis study in freely moving rats
36. Cholecystokinin innervation of the ventral striatum: A morphological, and radioimmunological study